Point72 Asset Management, L.P.

13F Holdings History for CytomX Therapeutics, Inc. - Common Stock, $0.00001 par value per share (CTMX)

Symbol: CTMX on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value per share
Latest Disclosed Ownership: 8.08M shares
Security Ownership: 5.1%

Shares, Excluding Options vs Price

Value, Excluding Options

Point72 Asset Management, L.P. ownership in CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

2025-08-14 - Point72 Asset Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 8.08M shares of CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX). This represents 5.1% percent ownership of the company. In their previous filing dated 2025-05-14, Point72 Asset Management, L.P. had reported owning 13.1M shares, indicating a decrease of -38.3% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Point72 Asset Management, L.P.	5.1%	-40%	$16.2M	8.08M	-5,009,777	-38.3%	$2.00	13G/A	6/30/2025	14 Aug 2025 17:30:37
Point72 Asset Management, L.P.	8.3%		$6.94M	13.1M			$0.53	13G	5/12/2025	14 May 2025 17:14:47

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.04%	+0.03%	$18.4M	8.08M	+5,434,623	+205%	$2.27	Q2 2025
3/31/2025	0%		$1.68M	2.65M			$0.64	Q1 2025
12/31/2024	0.01%	+0.01%	$2.73M	2.65M	+2,650,000	NEW	$1.03	Q4 2024
9/30/2022		-0.02%	$0	0	-2,750,000	-100%		Q3 2022
6/30/2022	0.02%	-0.01%	$5.03M	2.75M	-1,621,300	-37.1%	$1.83	Q2 2022
3/31/2022	0.05%	-0.02%	$11.7M	4.37M	-1,931,725	-30.6%	$2.67	Q1 2022
12/31/2021	0.11%		$27.3M	6.3M			$4.33	Q4 2021
9/30/2021	0.15%	0%	$32.1M	6.3M	-90,875	-1.42%	$5.09	Q3 2021
6/30/2021	0.2%	+0%	$40.5M	6.39M	+58,900	+0.93%	$6.33	Q2 2021
3/31/2021	0.25%	+0.23%	$49M	6.34M	+6,210,000	+4968%	$7.73	Q1 2021
12/31/2020	0%	+0%	$819K	125K	+125,000	NEW	$6.55	Q4 2020
9/30/2020		-0.06%	$0	0	-1,033,406	-100%		Q3 2020
6/30/2020	0.06%	+0.04%	$8.61M	1.03M	+816,842	+377%	$8.33	Q2 2020
3/31/2020	0.01%	-0.03%	$1.66M	217K	-504,436	-70%	$7.67	Q1 2020
12/31/2019	0.03%	+0.03%	$5.99M	721K	+721,000	NEW	$8.31	Q4 2019
9/30/2019		-0.02%	$0	0	-330,498	-100%		Q3 2019
6/30/2019	0.02%	-0.02%	$3.71M	330K	-295,151	-47.2%	$11.22	Q2 2019
3/31/2019	0.03%	-0.04%	$6.73M	626K	-838,147	-57.3%	$10.75	Q1 2019
12/31/2018	0.11%	+0.01%	$22.1M	1.46M	+136,056	+10.2%	$15.10	Q4 2018
9/30/2018	0.1%	+0.09%	$24.6M	1.33M	+1,169,569	+739%	$18.50	Q3 2018
6/30/2018	0.01%	+0.01%	$3.62M	158K	+158,171	NEW	$22.86	Q2 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.